Novavax

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza... Wikipedia

  • Type:  Public company
  • Traded as:  NASDAQ: NVAX, Russell 2000 component, FWB
  • ISIN:  [ ISIN: [ US6700024010]]
  • Industry:  Biotechnology
  • Founded:  1987
  • Area served:  Worldwide
  • Key people:  John Jacobs (CEO), Filip Dubovsky (R&D)
  • Products:  Vaccines
  • Revenue:  US$1.982 billion (2022)
  • Number of employees:  1,541(2022)
  • Data source:  DuckDuckGo